|
1
|
Xu Y, Wang L, He J, Bi Y, et al:
Prevalence and control of diabetes in Chinese adults. JAMA.
310:948–959. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tack CJ, Stienstra R, Joosten LA and Netea
MG: Inflammation links excess fat to insulin resistance: The role
of the interleukin-1 family. Immunol Rev. 249:239–252. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Oh YS, Lee YJ, Park EY and Jun HS:
Interleukin-6 treatment induces beta-cell apoptosis via
STAT-3-mediated nitric oxide production. Diabetes Metab Res Rev.
27:813–819. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kahn BB: Type 2 diabetes: When insulin
secretion fails to compensate for insulin resistance. Cell.
92:593–596. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Banerjee M and Saxena M: Interleukin-1
(IL-1) family of cytokines: Role in type 2 diabetes. Clin Chim
Acta. 413:1163–1170. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pradhan AD, Manson JE, Rifai N, Buring JE
and Ridker PM: C-reactive protein, interleukin 6 and risk of
developing type 2 diabetes mellitus. JAMA. 286:327–334. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Spranger J, Kroke A, Mohlig M, Hoffmann K,
Bergmann MM, Ristow M, Boeing H and Pfeiffer AF: Inflammatory
cytokines and the risk to develop type 2 diabetes: Results of the
prospective population-based European Prospective Investigation
into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes.
52:812–817. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miller AM, Asquith DL, Hueber AJ, Anderson
LA, Holmes WM, McKenzie AN, Xu D, Sattar N, McInnes IB and Liew FY:
Interleukin-33 induces protective effects in adipose tissue
inflammation during obesity in mice. Circ Res. 107:650–658. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Coglianese EE, Larson MG, Vasan RS, Ho JE,
Ghorbani A, McCabe EL, Cheng S, Fradley MG, Kretschman D, Gao W, et
al: Distribution and clinical correlates of the interleukin
receptor family member soluble ST2 in the Framingham Heart Study.
Clin Chem. 58:1673–1681. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miller AM, Purves D, McConnachie A,
Asquith DL, Batty GD, Burns H, Cavanagh J, Ford I, McLean JS,
Packard CJ, et al: Soluble ST2 associates with diabetes but not
established cardiovascular risk factors: A new inflammatory pathway
of relevance to diabetes? PLoS One. 7:e478302012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marques-Vidal P, Schmid R, Bochud M,
Bastardot F, von Kanel R, Paccaud F, Glaus J, Preisig M, Waeber G
and Vollenweider P: Adipocytokines, hepatic and inflammatory
biomarkers and incidence of type 2 diabetes. The CoLaus study. PLoS
One. 7:e517682012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ali S, Huber M, Kollewe C, Bischoff SC,
Falk W and Martin MU: IL-1 receptor accessory protein is essential
for IL-33-induced activation of T lymphocytes and mast cells. Proc
Natl Acad Sci USA. 104:18660–18665. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wesche H, Korherr C, Kracht M, Falk W,
Resch K and Martin MU: The interleukin-1 receptor accessory protein
(IL-1RAcP) is essential for IL-1-induced activation of
interleukin-1 receptor-associated kinase (IRAK) and
stress-activated protein kinases (SAP kinases). J Biol Chem.
272:7727–7731. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Z, Zheng C, Tan YY, Li YJ, Yang L,
Huang G, Lin J and Zhou ZG: Gene expression changes in patients
with fulminant type 1 diabetes. Chin Med J (Engl). 124:3613–3617.
2011.PubMed/NCBI
|
|
15
|
He MA, Zhang X, Wang J, Cheng L, Zhou L,
Zeng H, Wang F, Chen Y, Xu Z, Wei Q, et al: Genetic variation in
heat shock protein 60 gene and coronary heart disease in China:
tagging-SNP haplotype analysis in a case-control study. Cell Stress
Chaperones. 13:231–238. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liew FY, Pitman NI and McInnes IB:
Disease-associated functions of IL-33: The new kid in the IL-1
family. Nat Rev Immunol. 10:103–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
McLaren JE, Michael DR, Salter RC, Ashlin
TG, Calder CJ, Miller AM, Liew FY and Ramji DP: IL-33 reduces
macrophage foam cell formation. J Immunol. 185:1222–1229. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miller AM, Xu D, Asquith DL, Denby L, Li
Y, Sattar N, Baker AH, McInnes IB and Liew FY: IL-33 reduces the
development of atherosclerosis. J Exp Med. 205:339–346. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wood IS, Wang B and Trayhurn P: IL-33, a
recently identified interleukin-1 gene family member, is expressed
in human adipocytes. Biochem Biophys Res Commun. 384:105–109. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zeyda M, Wernly B, Demyanets S, Kaun C,
Hammerle M, Hantusch B, Schranz M, Neuhofer A, Itariu BK, Keck M,
et al: Severe obesity increases adipose tissue expression of
interleukin-33 and its receptor ST2, both predominantly detectable
in endothelial cells of human adipose tissue. Int J Obes.
37:658–665. 2013. View Article : Google Scholar
|
|
21
|
Zdravkovic N, Pavlovic S, Zdravkovic V,
Pejnovic N, Arsenijevic N and Lukic ML: ST2 gene-deletion reveals a
role of Foxp3+ regulatory T cells in diabetes modulation in BALB/c
mice. Transl Res. 161:118–129. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zdravkovic N, Shahin A, Arsenijevic N,
Lukic ML and Mensah-Brown EP: Regulatory T cells and ST2 signaling
control diabetes induction with multiple low doses of
streptozotocin. Mol Immunol. 47:28–36. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ehses JA, Lacraz G, Giroix MH, Schmidlin
F, Coulaud J, Kassis N, Irminger JC, Kergoat M, Portha B,
Homo-Delarche F, et al: IL-1 antagonism reduces hyperglycemia and
tissue inflammation in the type 2 diabetic GK rat. Proc Natl Acad
Sci USA. 106:13998–14003. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lucas R, Parikh SJ, Sridhar S, Guo DH,
Bhagatwala J, Dong Y, Caldwell R, Mellor A, Caldwell W, Zhu H, et
al: Cytokine profiling of young overweight and obese female African
American adults with prediabetes. Cytokine. 64:310–315. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Palmer G, Lipsky BP, Smithgall MD,
Meininger D, Siu S, Talabot-Ayer D, Gabay C and Smith DE: The IL-1
receptor accessory protein (AcP) is required for IL-33 signaling
and soluble AcP enhances the ability of soluble ST2 to inhibit
IL-33. Cytokine. 42:358–364. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Smeets RL, van de Loo FA, Joosten LA,
Arntz OJ, Bennink MB, Loesberg WA, Dmitriev IP, Curiel DT, Martin
MU and van den Berg WB: Effectiveness of the soluble form of the
interleukin-1 receptor accessory protein as an inhibitor of
interleukin-1 in collagen-induced arthritis. Arthritis Rheum.
48:2949–2958. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Smith DE, Hanna R, Della Friend, Moore H,
Chen H, Farese AM, MacVittie TJ, Virca GD and Sims JE: The soluble
form of IL-1 receptor accessory protein enhances the ability of
soluble type II IL-1 receptor to inhibit IL-1 action. Immunity.
18:87–96. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shaw JE and Chisholm DJ: 1: Epidemiology
and prevention of type 2 diabetes and the metabolic syndrome. Med J
Aust. 179:379–383. 2003.PubMed/NCBI
|
|
29
|
Eriksson J, Lindstrom J and Tuomilehto J:
Potential for the prevention of type 2 diabetes. Br Med Bull.
60:183–199. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
McEvoy LK, Kritz-Silverstein D,
Barrett-Connor E, Bergstrom J and Laughlin GA: Changes in alcohol
intake and their relationship with health status over a 24-year
follow-up period in community-dwelling older adults. J Am Geriatr
Soc. 61:1303–1308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shimomura T and Wakabayashi I: Inverse
associations between light-to-moderate alcohol intake and
lipid-related indices in patients with diabetes. Cardiovasc
Diabetol. 12:1042013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tentolouris N, Andrianakos A, Karanikolas
G, Karamitsos D, Trontzas P, Krachtis P, Christoyannis F,
Tavaniotou E, Nikolia Z, Kaskani E, et al: Type 2 diabetes mellitus
is associated with obesity, smoking and low socioeconomic status in
large and representative samples of rural, urban and suburban adult
Greek populations. Hormones (Athens). 11:458–467. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kengne AP, Nakamura K, Barzi F, Lam TH,
Huxley R, Gu D, Patel A, Kim HC and Woodward M: Asia Pacific Cohort
Study Collaboration: Smoking, diabetes and cardiovascular diseases
in men in the Asia Pacific region. J Diabetes. 1:173–181. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pathak R and Pathak A: Study of life style
habits on risk of type 2 diabetes. Int J Appl Basic Med Res.
2:92–96. 2012. View Article : Google Scholar : PubMed/NCBI
|
